These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20736460)

  • 1. As use of foreign drug trials grows, FDA oversight may not be keeping up.
    Mitka M
    JAMA; 2010 Aug; 304(8):843-4. PubMed ID: 20736460
    [No Abstract]   [Full Text] [Related]  

  • 2. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR; Orloff JJ
    J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
    [No Abstract]   [Full Text] [Related]  

  • 3. Can the FDA improve oversight of foreign clinical trials?: Closing the information gap and moving towards a globalized regulatory scheme.
    Ourso A
    Ann Health Law; 2012; 21(2):493-511, 4 p preceding i. PubMed ID: 22606923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric drug development in anesthesiology: an FDA perspective.
    Schultheis LW; Mathis LL; Roca RA; Simone AF; Hertz SH; Rappaport BA
    Anesth Analg; 2006 Jul; 103(1):49-51. PubMed ID: 16790624
    [No Abstract]   [Full Text] [Related]  

  • 5. Does the FDA have the authority to trump the Declaration of Helsinki?
    Goodyear MD; Lemmens T; Sprumont D; Tangwa G
    BMJ; 2009 Apr; 338():b1559. PubMed ID: 19383751
    [No Abstract]   [Full Text] [Related]  

  • 6. Another meeting on the Helsinki Declaration.
    Bull Med Ethics; 2001 Mar; (166):13-4. PubMed ID: 11878333
    [No Abstract]   [Full Text] [Related]  

  • 7. Preventing a New Tuskegee: Food and Drug Administration Oversight of Overseas Research Must Match That in the United States.
    White CM; White LR
    J Clin Pharmacol; 2022 Mar; 62(3):434-437. PubMed ID: 34592028
    [No Abstract]   [Full Text] [Related]  

  • 8. They are from the government and they really are here to help you.
    Woosley RL
    J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulatory and scientific issues regarding use of foreign data in support of new drug applications in the United States: an FDA perspective.
    Khin NA; Yang P; Hung HM; Maung-U K; Chen YF; Meeker-O'Connell A; Okwesili P; Yasuda SU; Ball LK; Huang SM; O'Neill RT; Temple R
    Clin Pharmacol Ther; 2013 Aug; 94(2):230-42. PubMed ID: 23588316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The conduct of clinical trials and good clinical practices: the sponsor's perspective. Food and Drug Administration.
    Robb EJ; Davis DD; Farrington DO
    J Anim Sci; 1995 Feb; 73(2):614-9; discussion 619-21. PubMed ID: 7601798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human subject protection; foreign clinical studies not conducted under an investigational new drug application. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Apr; 73(82):22800-16. PubMed ID: 18567164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA steps up efforts to find, remove violators of clinical trial regulations.
    Kuehn BM
    JAMA; 2009 Oct; 302(16):1739-41. PubMed ID: 19861661
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA tightens human oversight.
    Dove A
    Nat Med; 2001 Jun; 7(6):646. PubMed ID: 11385485
    [No Abstract]   [Full Text] [Related]  

  • 14. The responsibilities of investigators, monitors, and sponsors of clinical studies supporting new animal drug applications. Center for Veterinary Medicine, FDA.
    Schoenemann HM; McCormack JF; Smedley KO
    J Anim Sci; 1995 Feb; 73(2):606-13; discussion 612-3. PubMed ID: 7601797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical and scientific implications of the globalization of clinical research.
    Andrews CA
    N Engl J Med; 2009 Jun; 360(26):2793; author reply 2793. PubMed ID: 19557890
    [No Abstract]   [Full Text] [Related]  

  • 16. Information needed to conduct first-in-human oncology trials in the United States: a view from a former FDA medical reviewer.
    Senderowicz AM
    Clin Cancer Res; 2010 Mar; 16(6):1719-25. PubMed ID: 20215544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charging for investigational drugs under an investigational new drug application. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Aug; 74(155):40871-900. PubMed ID: 19691172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scientific community. African study raises ethical issues.
    Enserink M
    Science; 2003 Dec; 302(5653):2056. PubMed ID: 14684800
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA clears drug trials to combat systemic CMV.
    AIDS Patient Care STDS; 1997 Aug; 11(4):295-6. PubMed ID: 11361854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.